Core Insights - Israel Corporation Ltd. (ILCO) reported its second quarter results for the period ending June 30, 2025, showing a net profit of $43 million, a decrease from $48 million in the same quarter of the previous year [2]. Financial Performance - ILCO's share in ICL profit decreased to $40 million from $50 million year-over-year [2]. - ILCO's share in Prodalim profit increased to $2 million from a loss in the previous year [2]. - The net profit attributable to the company's shareholders was $43 million, down from $48 million in Q2 2024 [2]. Liquidity Position - As of June 30, 2025, total financial liabilities stood at $715 million, while investments in liquid assets were $739 million, including $8 million in pledged deposits [3]. - Net cash totaled $26 million, an increase from $21 million as of March 31, 2025 [3]. Asset Overview - Total assets as of June 30, 2025, amounted to $4,070 million, with significant holdings including approximately $3,883 million in ICL and $118 million in Prodalim [6]. - ILCO's net cash position was reported at $26 million, leading to total net assets of $4,096 million [6]. Strategic Developments - ILCO completed an investment agreement with Prodalim, acquiring approximately 27.5% of its share capital, focusing on natural solutions for various industries [4]. - The Board of Directors approved a dividend distribution of $15 million, consistent with the company's dividend policy [4]. Company Profile - Israel Corporation Ltd. is a public investment company focused on high-quality companies, with core holdings including a 44% stake in ICL Group and an 18% stake in AKVA Group [8]. - The company aims to expand its portfolio in sectors such as food, agriculture, healthcare, and Industry 4.0 [7][8].